BRVE: the cash flow

Cash Flow Overview

Change in Cash

$33,670K

Free Cash flow

-$22,164K

Unit: Thousand (K) dollars

Positive Cash Flow Breakdown

Negative Cash Flow Breakdown

Cash Flow

2026-06-30

Net loss

-29,268

Acquired in-process research and development

Depreciation and amortization

Stock-based compensation

2,846

Prepaid expenses and other current assets

462

Accounts payable

936

Accrued expenses and other current liabilities (includes related party amounts of 389 and 0, respectively)

3,912

Operating lease right-of-use asset and lease liabilities

105

Net cash used in operating activities

-22,136

Cash paid for purchased in-process research and development (includes related party amounts of 3,000 and 0, respectively)

3,000

Purchase of property and equipment

Net cash used in investing activities

-3,028

Proceeds from issuance of common stock

Proceeds from issuance of series a redeemable convertible preferred stock, net of issuance costs

59,596

Payments for deferred offering costs

762

Net cash provided by financing activities

58,834

Net increase in cash and cash equivalents for the period

33,670

Cash and cash equivalents at beginning of the period

89,161

Cash and cash equivalents at end of the period

122,831

Time Plot

Show the time plot by selecting a row from the table.